FORMULATIONS AND DOSAGES FOR ADMINISTERING COMPOUND THAT INHIBITS MCL1 PROTEIN

To provide pharmaceutical formulations for treating a patient having cancer including a hematological malignancy.SOLUTION: Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RON C KELLY, MICHAEL T KENNEDY, STEVEDAT K LA
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide pharmaceutical formulations for treating a patient having cancer including a hematological malignancy.SOLUTION: Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.SELECTED DRAWING: Figure 1 【課題】血液学的悪性腫瘍を含む癌を有する患者において治療するための医薬製剤を提供する。【解決手段】式Ｉの化合物の製剤は、例えば、急性骨髄性白血病、多発性骨髄腫及び非ホジキンリンパ腫等の血液学的悪性腫瘍を含む癌を治療する方法において有用である用量及び投与計画と同様に提供される。TIFF2024112842000038.tif79170【選択図】図１